To further support the expansion of A&L Canada Laboratories diagnostic capabilities, the Disease Diagnostics Lab has acquired a Next-Generation Sequencer (NGS) instrument. This will assist in virus and viroid detection as well as many other genomic services clients might need. The new instrumentation will also improve A&L Canada Laboratories industry leading turnaround times in disease diagnostics. This service will be available to clients in the upcoming weeks.
top of page
bottom of page